We therefore wanted to investigate which of these regulatory effects of Fra-2 operate in an in vivo model of breast cancer metastasis and focused on E- and P-selectin-binding sites as the first receptors of the leukocyte adhesion cascade. The gene discussed is SELP; the disease is breast carcinoma.